• CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir
  • CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir
  • CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir
  • CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir
  • CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir
  • CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir

CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Powder
Purity: >99%
Samples:
US$ 100/kg 1 kg(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
D-sung Ledipasvir
Product Name
Ledipasvir
Name
Ledipasvir Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Anti HCV
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
1256388-51-8
Mf
C49h54f2n8o6
MW
889.00
Density
1.42±0.1 (20 Oc 760 Torr)
Storage
Normal
Transport Package
Negotiable
Specification
99%
Trademark
D-sung
Origin
Shaanxi Xi′an
Production Capacity
1000kg/Month

Product Description

CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir
CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder Api Ledipasvir
Product Description
CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API LedipasvirCAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir
Product Details
CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir
Product name Ledipasvir
Cas number 1256388-51-8
Appearance White powder
MF C49H54F2N8O6
MW 889.00
 
Ledipasvir (formerly GS-5885) is a drug for the treatment of hepatitis C, it is an inhibitor of the hepatitis C virus NS5A protein. The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin.
Application&Function
CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API LedipasvirLedipasvir is an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex,  ledipasvir is indicated for the treatment of HCV genotypes 1, 4, 5, and 6. Its use has also proven successful in the treatment of HCV in patients co-infected with HIV.
Specification
CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API LedipasvirCAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API LedipasvirCAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir
CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API LedipasvirCAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API LedipasvirCAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir
CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Management System Certification
ISO 9001, ISO 14001, GMP, HACCP